Taking a joined-up approach to cardiovascular prevention: addressing health inequalities by focusing on hypertension and lipid management

15 Jun 2022
Innovation zone
Innovation (AHSN)

Cardiovascular disease (CVD) is a major driver of health inequalities as well as premature death and disability from heart attacks and stroke. Controlling hypertension and lowering cholesterol in people at high CVD risk is critical to improving population health, which is why the Academic Health Science Networks (AHSNs) are leading a collaborative, targeted approach to tackle the problem through a pathway endorsed by NICE.

The AHSN Network is working with patients, HEART UK and NHS England and NHS Improvement on national programmes to improve cholesterol and lipid management, identify people with familial hypercholesterolaemia (FH) and optimise blood pressure. An equality health impact assessment has been developed and UCL Partners’ proactive care frameworks are being rolled out nationally, supporting primary care in identifying patients at highest CVD risk.

This session will showcase progress so far, share learning and highlight future ambitions.

This session is part of the Innovation Zone and is brought to you by The AHSN Network. The AHSN Network is a key partner in the Accelerated Access Collaborative (AAC) at NHS England.

Gary Ford, Chair AHSN Network and Chief Executive - Oxford AHSN
Joe Chidanyika, National Programme Manager - Lipids/FH, AHSN NENC - AHSN Network
Matt Kearney, Executive Clinical Director Cardiovascular Health - UCLPartners
Sian Rees, Director - Community Involvement & Workforce Innovation - Oxford Academic Health Science Network
AHSN Network